These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7505225)

  • 61. The intraprostatic spiral. New treatment for urinary retention.
    Nielsen KK; Klarskov P; Nordling J; Andersen JT; Holm HH
    Br J Urol; 1990 May; 65(5):500-3. PubMed ID: 1693866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
    Laaksovirta S; Isotalo T; Talja M; Välimaa T; Törmälä P; Tammela TL
    J Endourol; 2002 Jun; 16(5):311-5. PubMed ID: 12184083
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical study of a metallic prostatic stent].
    Yasumoto R; Yoshihara H; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1991 Nov; 37(11):1467-70. PubMed ID: 1722635
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention.
    Monoski MA; Gonzalez RR; Sandhu JS; Reddy B; Te AE
    Urology; 2006 Aug; 68(2):312-7. PubMed ID: 16904443
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention.
    Schelin S
    Eur Urol; 2001 Apr; 39(4):400-4. PubMed ID: 11306877
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine.
    Kehinde EO; Abul F
    Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Transurethral hyperthermic treatment in patients with benign prostatic hypertrophy].
    Yasumoto R; Kohno T; Nishikawa K; Fu O; Kawano M; Sakakura T; Kumata N; Yamamoto S; Asai Y; Yoshimura R
    Hinyokika Kiyo; 1994 May; 40(5):449-54. PubMed ID: 7517623
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.
    Laaksovirta S; Talja M; Välimaa T; Isotalo T; Törmälä P; Tammela TL
    J Urol; 2001 Sep; 166(3):919-22. PubMed ID: 11490246
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
    Gesenberg A; Sintermann R
    J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Application of urethral stent under metal bougie guidance].
    Isogawa Y; Ohmori K
    Hinyokika Kiyo; 1993 Mar; 39(3):231-5. PubMed ID: 7685141
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Local hyperthermia in benign prostatic hyperplasia].
    Bichler KH; Strohmaier WL; Flüchter SH
    Urologe A; 1991 Mar; 30(2):122-6. PubMed ID: 1711728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
    Dutkiewicz S; Stepień K; Witeska A
    Mater Med Pol; 1995; 27(2):71-3. PubMed ID: 8935194
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microwave thermotherapy in patients with chronic urinary retention.
    Djavan B; Wammack R; Ghawidel K; Alavi S; Hasenzagel C; Dobronski P; Stoklosa A; Jakubcky T; Borkowski A; Marberger M
    Tech Urol; 2000 Dec; 6(4):278-81. PubMed ID: 11108566
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Update evaluation of benign prostatic hyperplasia: when should we offer prostatectomy?
    Cetinel B; Turan T; Talat Z; Yalçin V; Alici B; Solok V
    Br J Urol; 1994 Nov; 74(5):566-71. PubMed ID: 7530119
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
    Magoha GA
    East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.